APAC
NSC, MTDR ink tattoo removal deal
NSC, MTDR ink tattoo removal deal
The agreement enables clinically supervised access under MKH.
Healthcare analytics market to reach $203.23b by 2034
The market was valued at $52.59b in 2024.
Australia commits $80.33m to 60 medical research projects
The funding spans four national health priorities.
Asia medical waste container market to jump 7.6% by 2034 as healthcare infra expands
Infectious diseases, increased hospital admissions, and medical tourism will cause higher waste volumes in the region.
Digital immunoassays to reach $7.1b by 2036
Protein biomarker assays will remain the largest segment.
SingHealth targets workforce readiness through new HMI agreement
Agreement expands practice-led training framework
Taiwan hospital shortens hospitalisation for 19% of TAVR patients
The workflow cuts ICU use and shortens hospital stays.
Saudi health spending to climb 6.7% CAGR to $98.8b by 2030
Public funding will moderate as private investment accelerates.
Diagnosed head and neck cancer cases in urban China to grow 3.55% annually
The forecast covers newly diagnosed incidence from 2024 to 2034.
Predictive clinical biomarkers market could grow 73% to $14.69b by 2030
MarketsandMarkets estimated a CAGR of 11.6% over the five-year period.
Industrial policy to reshape global health product value chains over five years
Policy reaches to extend from raw materials to procurement.
King’s College Hospital deploys Da Vinci Xi for minimally invasive procedures
The system provides 3D visualisation and robotic instrumentation.
Asia-Pacific to see fastest growth in SMRT sequencing through 2030
Thanks to rising public and private investment in genomics.
It's the most wonderful time of the year!
See you in 2026!
At-home syphilis test kit market to grow $1.25b
Asia Pacific leads growth in at-home syphilis testing.
Global dental laboratories market projected to reach $13.09b by 2030
Asia Pacific dental labs expected highest CAGR growth.
IoMT market forecast to reach $257.16b by 2030
Chronic disease and remote monitoring will underpin this growth.
Commentary
Beyond symptom control: Redefining IMID care in Malaysia
How decentralised clinical trials can unlock Asia's research potential
Why health system research deserves more attention